Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1483
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG.NO.IH0220004-
dc.date.accessioned2023-07-25T07:24:40Z-
dc.date.available2023-07-25T07:24:40Z-
dc.date.issued2023-07-25-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1483-
dc.description.abstractINTRODUCTION: Oral Squamous Cell Carcinoma (OSCC) constitutes the most prevalent oral cavity cancer. It exhibits an elevated level of local aggressiveness, invasion and involvement of lymphatics, as well as a significant mortality rate. OSCC is mostly preceded by the appearance of precursor lesions with varying degrees of malignant transformation potential. OSCC development and progression are regulated by a variety of molecular mechanisms and pathways. CDK14 belongs to the cyclin- dependent kinase (CDK) menage, which is involved in cancer tumorigenesis. It is found expressed in different types of tumours, including ovarian cancer, hepatocellular carcinoma (HCC), gastric carcinoma, breast cancer, and oesophageal squamous cell carcinoma (ESCC). However, its expression and role in normal oral mucosa (OM), Oral epithelial dysplasia (OED), and OSCC unknown. As a result, the study was directed to examine the expression of CDK14 in normal oral mucosa, OED, and OSCC.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectOral Squamous Cell Carcinoma, OSCC, CDK14, PFTK1 Oral normal mucosa, Oral epithelial dysplasia , OEDen_US
dc.titleEvaluation of immunoexpression Of cdk14 in normal oral mucosa, Oral epithelial dysplasia and oral Squamous cell carcinomaen_US
dc.typeDissertationsen_US
Appears in Collections:Oral Pathology & Microbiology

Files in This Item:
File Description SizeFormat 
IH0220004.pdf5.17 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.